74 related articles for article (PubMed ID: 7656930)
1. SSCP detection of N-ras promoter mutations in AML patients.
Thorn J; Molloy P; Iland H
Exp Hematol; 1995 Sep; 23(10):1098-103. PubMed ID: 7656930
[TBL] [Abstract][Full Text] [Related]
2. Analysis of mutations of neurofibromatosis type 1 gene and N-ras gene in acute myelogenous leukemia.
Lee YY; Kim WS; Bang YJ; Jung CW; Park S; Yoon WJ; Cho KS; Kim IS; Jung TJ; Choi IY
Stem Cells; 1995 Sep; 13(5):556-63. PubMed ID: 8528106
[TBL] [Abstract][Full Text] [Related]
3. Epigenetic and genetic analysis of the survivin promoter in acute myeloid leukemia.
Wagner M; Schmelz K; Dörken B; Tamm I
Leuk Res; 2008 Jul; 32(7):1054-60. PubMed ID: 18206228
[TBL] [Abstract][Full Text] [Related]
4. [Molecular study on minute alterations of the p53 and the N-ras genes in hematologic malignancies].
Kurosawa M
Hokkaido Igaku Zasshi; 1994 May; 69(3):543-54. PubMed ID: 7927179
[TBL] [Abstract][Full Text] [Related]
5. The proximal promoter of the human cathepsin G gene conferring myeloid-specific expression includes C/EBP, c-myb and PU.1 binding sites.
Lennartsson A; Garwicz D; Lindmark A; Gullberg U
Gene; 2005 Aug; 356():193-202. PubMed ID: 16019164
[TBL] [Abstract][Full Text] [Related]
6. DNA polymorphisms in potential regulatory elements of the CFTR gene alter transcription factor binding.
Rowntree R; Harris A
Hum Genet; 2002 Jul; 111(1):66-74. PubMed ID: 12136238
[TBL] [Abstract][Full Text] [Related]
7. Frequency of RAS gene mutation and its cooperative genetic events in Southeast Asian adult acute myeloid leukemia.
Auewarakul CU; Lauhakirti D; Tocharoentanaphol C
Eur J Haematol; 2006 Jul; 77(1):51-6. PubMed ID: 16573741
[TBL] [Abstract][Full Text] [Related]
8. A point mutation affecting an SP1 binding site in the promoter of the ferrochelatase gene impairs gene transcription and causes erythropoietic protoporphyria.
Di Pierro E; Cappellini MD; Mazzucchelli R; Moriondo V; Mologni D; Zanone Poma B; Riva A
Exp Hematol; 2005 May; 33(5):584-91. PubMed ID: 15850836
[TBL] [Abstract][Full Text] [Related]
9. Naturally occurring mutations in the human 5-lipoxygenase gene promoter that modify transcription factor binding and reporter gene transcription.
In KH; Asano K; Beier D; Grobholz J; Finn PW; Silverman EK; Silverman ES; Collins T; Fischer AR; Keith TP; Serino K; Kim SW; De Sanctis GT; Yandava C; Pillari A; Rubin P; Kemp J; Israel E; Busse W; Ledford D; Murray JJ; Segal A; Tinkleman D; Drazen JM
J Clin Invest; 1997 Mar; 99(5):1130-7. PubMed ID: 9062372
[TBL] [Abstract][Full Text] [Related]
10. N-ras mutations in radiation-induced murine leukemic cells.
Rithidech KN; Dunn JJ; Gordon CR; Cronkite EP; Bond VP
Blood Cells Mol Dis; 1996; 22(3):271-80. PubMed ID: 9075579
[TBL] [Abstract][Full Text] [Related]
11. Novel loss-of-function mutations of the haematopoiesis-related transcription factor, acute myeloid leukaemia 1/runt-related transcription factor 1, detected in acute myeloblastic leukaemia and myelodysplastic syndrome.
Nakao M; Horiike S; Fukushima-Nakase Y; Nishimura M; Fujita Y; Taniwaki M; Okuda T
Br J Haematol; 2004 Jun; 125(6):709-19. PubMed ID: 15180860
[TBL] [Abstract][Full Text] [Related]
12. A dinucleotide deletion in the ankyrin promoter alters gene expression, transcription initiation and TFIID complex formation in hereditary spherocytosis.
Gallagher PG; Nilson DG; Wong C; Weisbein JL; Garrett-Beal LJ; Eber SW; Bodine DM
Hum Mol Genet; 2005 Sep; 14(17):2501-9. PubMed ID: 16037067
[TBL] [Abstract][Full Text] [Related]
13. Activating BRAF and N-Ras mutations in sporadic primary melanomas: an inverse association with allelic loss on chromosome 9.
Kumar R; Angelini S; Hemminki K
Oncogene; 2003 Dec; 22(58):9217-24. PubMed ID: 14681681
[TBL] [Abstract][Full Text] [Related]
14. Myb binding sites within the N-ras promoter repress transcription.
Ganter B; Lipsick JS
Oncogene; 1997 Jul; 15(2):193-202. PubMed ID: 9244354
[TBL] [Abstract][Full Text] [Related]
15. Alterations of the p53 tumor suppressor gene and its association with activation of the c-K-ras-2 protooncogene in premalignant and malignant lesions of the human uterine endometrium.
Enomoto T; Fujita M; Inoue M; Rice JM; Nakajima R; Tanizawa O; Nomura T
Cancer Res; 1993 Apr; 53(8):1883-8. PubMed ID: 8385572
[TBL] [Abstract][Full Text] [Related]
16. 12th codon mutation resulting in c-N-ras activation in acute myelogenous leukemia.
Needleman SW; Devine SE; Kraus MH
Leukemia; 1988 Feb; 2(2):91-3. PubMed ID: 3278172
[TBL] [Abstract][Full Text] [Related]
17. Oncogenic Ras can induce transcriptional activation through a variety of promoter elements, including tandem c-Ets-2 binding sites.
Galang CK; Der CJ; Hauser CA
Oncogene; 1994 Oct; 9(10):2913-21. PubMed ID: 8084596
[TBL] [Abstract][Full Text] [Related]
18. [Activation of ras oncogene in myelodysplastic syndrome and acute myelogenous leukemia].
Hirai H; Hirano N; Yazaki Y
Gan To Kagaku Ryoho; 1991 Jun; 18(7):1090-7. PubMed ID: 2053767
[TBL] [Abstract][Full Text] [Related]
19. Somatic CEBPA mutations are a frequent second event in families with germline CEBPA mutations and familial acute myeloid leukemia.
Pabst T; Eyholzer M; Haefliger S; Schardt J; Mueller BU
J Clin Oncol; 2008 Nov; 26(31):5088-93. PubMed ID: 18768433
[TBL] [Abstract][Full Text] [Related]
20. Risk assessment in patients with acute myeloid leukemia and a normal karyotype.
Bienz M; Ludwig M; Leibundgut EO; Mueller BU; Ratschiller D; Solenthaler M; Fey MF; Pabst T
Clin Cancer Res; 2005 Feb; 11(4):1416-24. PubMed ID: 15746041
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]